Ambassadors’ accomplishments
Since the beginning of 2020, the international network of AMR Insights Ambassadors has sparked a series of impactful initiatives. Below are just a few examples of the groundbreaking projects and collaborations that have emerged, showcasing the network’s dedication to addressing antimicrobial resistance and driving meaningful change worldwide.
Publications
Thanks to the initiative of our Ambassadors, dynamic writing teams have been spontaneously formed, resulting in a wealth of publications in esteemed professional and peer-reviewed journals. These collaborative efforts highlight the expertise and commitment of our network in advancing the knowledge and solutions surrounding antimicrobial resistance:
I) Impact of antimicrobial use in animals on antimicrobial resistance in humans (published)
II) The COVID-19 pandemic and its effect on antimicrobial and biocide resistance: An AMR Insights’ global perspective (published)
III) Looking for solutions to the pitfalls of developing novel antibacterials in an economically challenging system (published)
IV) Herbicides and their impact on antimicrobial resistance in the context of food and food safety (published)
V) White Paper Removal of antibiotics and pharmaceutical residues in water urgent (published on an in-house basis)
VI) The notorious case of Campylobacter spp.: an increasingly antimicrobialresistant foodborne pathogen (published)
VII) Antibiotic Discovery and Resistance: The Chase and the Race (published)
VIII) Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics (published)
IX) Perspectives on the Ethics of Antibiotic Overuse and on the Implementation of (New) Antibiotics (published)
Other publications with AMR Insights contributions (not with Ambassadors)
I) AMR policy dialogue:driving innovative solutions for antimicrobial discovery (published)
II) Report AMR Global Expert Mission Germany (released)
III) Applying data technologies to combat AMR: current status, challenges, and opportunities on the way forward (published)
IV) Roadmap towards the sustainable discovery and development of new antibiotics (published)
V) Introducing the global antimicrobial stewardship partnership hub (GASPH): creating conditions for successful global partnership collaboration (published)
VI) Using a pharmacist-led educational tool to teach elementary and middle-school students in Lebanon about microbes, antibiotic use and antimicrobial resistance: A pilot study (published)
VII) Global Expert Mission Antimicrobial Resistance US 2022 (released)
VIII) Global Expert Mission Antimicrobial Resistance India 2023 (released)
IX) Ten simple rules for the sharing of bacterial genotype—Phenotype data on antimicrobial resistance (published)
X) Over-the-counter sales of high-priority antibiotics is common: results of a global survey (Abstract)
XI) Unifying genomic datasets: Leveraging metadata standardization for AMR interpretation in a One-Health context (Abstract ICAFA 2023)
XII) Microbiome and antimicrobial resistance from a One-Health perspective (Abstract ICAFA 2023)
XIII) Antimicrobiële resistentie (AMR) is een verborgen pandemie: “Jaarlijks overlijden miljoenen mensen aan de gevolgen van AMR” (Interview; in Dutch language)
XIV) The incidence of bacterial pneumonia, antibiotic resistance and antibiotic use in hospitals in six countries during the COVID-19 pandemic (Abstract submitted to ECCMID 2024)
Podcasts
Projects
I) Multi-country Retrospective Analysis Bacterial Infection and Antimicrobial Resistance in COVID-19 inpatients
In close partnership with our Ambassadors’ Clinical Research Team and Statistical Research Team, we designed and executed a groundbreaking clinical study: “Multi-country Retrospective Analysis of Bacterial Infection and Antimicrobial Resistance in COVID-19 Inpatients.” Spanning across 7 countries and involving 15 hospitals, this comprehensive study provided crucial insights into the impact of antimicrobial resistance in the context of COVID-19. Successfully completed and reported in 2023, the study marks a significant contribution to global health research and the fight against antimicrobial resistance.
II) Dutch Consortium Antibiotics from Water
In close collaboration with Dutch Ambassadors Brigit van Soest (Association of Innovative Medicines, Dutch Generic and Biosimilar Medicines Association), Tom Vereijken (European Water Stewardship), and Maarten van Dongen, we proudly established the Dutch Public-Private Consortium ‘Antibiotics and Pharmaceutical Residues from Water.’ This forward-thinking initiative is dedicated to advancing technological solutions and boosting innovation to reduce emissions from antibiotic waste streams. By fostering collaboration between public and private sectors, the Consortium aims to make significant strides in addressing one of the most pressing environmental challenges linked to antimicrobial resistance.
III) AMR Engagement Group
The AMR Engagement Group (AEG) plays a vital role in raising awareness about the risks of antimicrobial resistance (AMR) among children and their carers, contributing to:
- A reduction in resistant infectious diseases in children
- Decreasing the spread of resistance
- Increasing global awareness of the growing resistance problem
Founded from the initiative of the Pennsylvania Consortium for Antimicrobial Stewardship (PCAS), the AEG is dedicated to connecting with similar initiatives worldwide, amplifying its efforts to tackle AMR on a global scale. Through this collaboration, the Group aims to create a lasting impact in the fight against antimicrobial resistance.e.
Ambassador Teams
The following professional Ambassador Teams have been established, each focusing on key areas to drive progress in the fight against antimicrobial resistance (AMR):
I) Clinical research team
II) Statistical research team
III) Modelling team
IV) Veterinary research team
V) Writing teams (ad hoc)
Blogs
The following insightful blogs were written by our dedicated Ambassadors, offering valuable perspectives and expertise on the pressing issue of antimicrobial resistance (AMR):